What's the Best Age to Start HRT in New Hampshire? Here's What the Evidence Actually Says

If you've been Googling "best age to start hormone therapy" at 2am, here's the truth: there isn't one number. Hormone therapy is not one size fits all, and anyone who tells you otherwise hasn't looked closely at the research.

Every woman follows a similar biological clock, but when that clock starts ringing, and how loudly, is completely individual. Genetics, medical history, even environment all play a role. So when a woman asks what age is right for her to start HRT, the honest answer is both simple and layered.

The Simplest Answer: You Start When You Need It

Women know their bodies. If you're taking the time to research hormone therapy, ask questions, and advocate for your own care, you probably already sense that something is off. Symptoms have likely become pervasive enough that you're now motivated to do something about them.

So the most straightforward answer to "when should I start HRT" is this: the best time is when you're symptomatic.

For most women, perimenopause symptoms can begin any time after 35, with the average landing around 45. That's a wide window, and it can last for years. There's no perfect age on a calendar. There's a moment when your body starts telling you something has shifted, and that's the moment worth paying attention to.

What Does the Clinical Evidence Say?

The Menopause Society released a position statement in 2022 stating that hormone therapy is generally beneficial for treating perimenopause symptoms in women under 60, or within 10 years of menopause. This is often called the timing hypothesis: the idea that younger, healthier cells respond best to a hormone boost. As cells age and begin to degenerate, hormone therapy may accelerate changes that are already underway.

Helpful, but also a little confusing in practice. A 44-year-old woman is clearly under 60, but is she within 10 years of menopause? She can't know that for certain. What we can say is that if her symptoms are significant enough to send her looking for treatment, it's reasonable to assume her ovaries are already declining, and she stands to benefit from starting care earlier rather than later.

Under 35 With Perimenopause-Like Symptoms? Get Evaluated First

Perimenopause symptoms before age 35 aren't typical. If that's you, the right first step isn't jumping straight to hormone therapy. It's ruling out other conditions that can mimic perimenopause, including thyroid dysfunction, nutritional deficiencies, or issues with the hypothalamic-pituitary axis. Getting the right diagnosis first means you get the right treatment, not just the most obvious one.

Over 60, or More Than a Decade Past Menopause? It Takes More Consideration

This group deserves a more careful conversation. Some research has linked HRT in this age range to an increased risk of cardiac events and accelerated neurodegenerative decline. Worth noting: the elevated cardiac risk appears concentrated in the first year of treatment and declines after that.

In April 2024 the Menopause Society released an updated article citing a newly released study of 10 million senior Medicare women showing that women older than 65 using estrogen only products had improved outcomes for cardiac, cancer and overall mortality, citing that type of hormone therapy is important, and that women older than 65 may be able to safely continue taking hormone therapy.

This is where individualized care matters most. A thorough review of medical history, along with baseline labs covering inflammatory markers and lipid panels, should happen before starting treatment. Once a thorough risk versus benefit conversation has taken place, if a woman decides the bone, metabolic, sleep, and libido benefits of HRT are worth pursuing, and her risk is relatively low otherwise, she has a right to choose HRT if she wants it. That's what we believe at Ember.

How Long Should You Stay on HRT?

Also her choice. There is no general rule to stop HRT based on age alone. It may be safe to stay on hormone therapy indefinitely with periodic evaluations, and it's safe to stop. If you do stop, expect that the symptoms you started treatment for may return. Broadly, the data supports that the earlier a woman starts HRT during perimenopause, the better her long-term outcomes tend to be.

A Note on Emerging Research

One study worth flagging looked specifically at vaginal estradiol, not systemic hormone therapy, across nearly 2 million women of all ages, including women in their 20s. It found that vaginal estradiol reduced mortaity by more than 2-fold compared to those not on vaginal estradiol. Again, this is not systemic hormone therapy and considered localized hormone therapy, but still, it's a striking number, and it's exactly why more research is needed before drawing firm conclusions. It's also a reminder that "hormone therapy" isn't one single treatment. The route, the dose, and the type all matter, and they should all be part of your conversation with a provider.

The Bottom Line

Hormone therapy risk isn't fixed. It shifts based on the specific formulation, the dose, how long it's used, how it's delivered, when treatment starts, and whether progestogen is part of the regimen. That's why care should never be templated. The right approach draws on the strongest available evidence to get the most benefit for the least risk, and it doesn't end at the first prescription. Providers and patients should revisit the risk-benefit picture regularly to decide whether continuing treatment still makes sense.

There's no universal starting line for hormone therapy. What matters is that you have options, you don't have to white-knuckle through symptoms, and you deserve a real, shared decision-making process with a provider who actually specializes in hormones, not a five-minute checkbox visit.

Curious where you actually are in the transition? Take our quiz: What Stage of Perimenopause Are You In?

Ready for guidance built around your body, not a generic protocol? Get personalized guidance for your stage with an Ember hormone specialist, serving women across New Hampshire and Massachusetts.